Bearish flow noted in Bristol Myers (BMY) Squibb with 13,765 puts trading, or 2x expected. Most active are Apr-25 60 puts and 4/4 weekly 60 puts, with total volume in those strikes near 8,600 contracts. The Put/Call Ratio is 2.16, while ATM IV is up nearly 2 points on the day. Earnings are expected on April 24th.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers Squibb call volume above normal and directionally bullish
- Bristol Myers’ treatment of small cell lung cancer gets FDA orphan designation
- Actinium Pharmaceuticals launches clinical trial for Actimab-A in combination
- Big pharma fears drug price spikes in US-EU tariff spat, Reuters says
- Perspective Therapeutics says first patient dosed in Phase 1/2a trial of VMT01
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue